The observed anthropometric and metabolic improvements are encouraging, yet the small sample size, and lack of a control group limit the strength of these findings and preclude definitive recommendations for routine clinical use
COMBI: metformin 1000 mg BID + liraglutide 1.2 mg/day (COMBI: n = 11) [61]
However, excess usage may cause gastrointestinal discomfort, fishy body odor (in sweat, breath, or urine), allergic reactions, stomach upset, diarrhea, and heartburn
Used for managing type 2 diabetes and obesity, semaglutide is a specialized medication, and ensuring its proper administration and patient adherence is essential for the success of any provider
Tirzepatide left at room temperature degrades over time